I3C was shown to trigger a p53-dependent apoptotic response in 10AT-Her2 cells and can disrupt tumorsphere formation in cell suspension cultures as well as inhibit the in vivo growth of 10AT-Her2-derived tumor xenografts. Here, ERBB2 is linked to neoplasm.